EOne

EOne
Name	EOne
Type	Private
Industry	Medical devices
Founded	2010
Headquarters	Boston, Massachusetts, United States
Key people	John Smith, Maria Gonzalez, Akira Tanaka
Products	Portable nebulizers, insulin delivery systems, respiratory monitors
Revenue	(undisclosed)
Employees	450

EOne is a medical device manufacturer specializing in portable respiratory and diabetes care systems. The company develops integrated hardware and firmware platforms that combine microelectromechanical components, wireless communications, and cloud analytics to support clinical workflows in hospitals and home settings. EOne collaborates with academic centers, regulatory bodies, and healthcare providers to translate engineering advances into commercial products.

History

EOne was founded in 2010 by engineers from Massachusetts Institute of Technology, Harvard Medical School, and Johns Hopkins University with seed funding from venture firms including Sequoia Capital, Andreessen Horowitz, and New Enterprise Associates. Early partnerships included research agreements with Boston Children's Hospital, Mayo Clinic, and Cleveland Clinic to validate aerosol delivery and glucose sensing technologies. The company expanded internationally through distribution pacts with GlaxoSmithKline, Sanofi, and Roche and opened R&D labs near Stanford University and University of Cambridge.

Milestones included a Series B round led by Kleiner Perkins and regulatory clearances filed with Food and Drug Administration and notified bodies in the European Union. EOne received awards from National Institutes of Health Small Business Innovation Research programs and collaborated on projects with DARPA and National Science Foundation. Key hires came from Philips Respironics, Medtronic, and GE Healthcare to scale manufacturing and clinical trials conducted at Johns Hopkins Hospital, Massachusetts General Hospital, and Mount Sinai Health System.

Technology and Products

EOne's core technologies integrate microfluidics, piezoelectric actuators, and embedded systems developed in collaboration with researchers at Carnegie Mellon University, University of California, Berkeley, and Imperial College London. Its flagship portable nebulizer uses ultrasonic atomization and adaptive feedback algorithms derived from studies at Sloan Kettering Institute and Dana-Farber Cancer Institute to optimize particle size for pulmonary delivery. The insulin delivery platform incorporates continuous glucose monitoring sensors and closed-loop control software influenced by work at University of Cambridge Metabolic Research Laboratories and Imperial College Diabetes Centre.

Firmware implements secure communication stacks compliant with protocols from Institute of Electrical and Electronics Engineers standards and encryption models from National Institute of Standards and Technology. EOne products feature interoperable APIs tested with electronic health record systems such as Epic Systems Corporation, Cerner Corporation, and Allscripts Healthcare Solutions. The company files patents with examiners at the United States Patent and Trademark Office and pursues certifications from Underwriters Laboratories and International Organization for Standardization.

Applications and Use Cases

Clinical applications include management of chronic obstructive pulmonary disease in collaboration with pulmonologists at American Thoracic Society conferences and treatment of cystic fibrosis patients following guidelines from Cystic Fibrosis Foundation. EOne devices are used in hospitals during perioperative care protocols at Johns Hopkins Hospital and in ambulatory care clinics managed by Kaiser Permanente and Mayo Clinic Health System. Diabetes therapeutics trials involve endocrinology groups at Joslin Diabetes Center and University of California, San Francisco.

Emergency and military medicine use cases were explored with partners such as United States Army Medical Research and Development Command and US Department of Veterans Affairs for deployment in field hospitals and veteran care. Global health initiatives utilized EOne technology in programs run by World Health Organization and Médecins Sans Frontières to support respiratory disease management in low-resource settings. Research collaborations include projects with Bill & Melinda Gates Foundation and implementation studies coordinated with Centers for Disease Control and Prevention.

Manufacturing and Distribution

EOne outsources volume manufacturing to contract manufacturers working with standards from Foxconn Technology Group, Jabil Inc., and Flex Ltd. while maintaining final assembly in facilities audited to ISO 13485 quality management systems and inspected by auditors from SGS S.A. and Bureau Veritas. Supply chain agreements involve component suppliers such as Texas Instruments, Analog Devices, STMicroelectronics, and sensor vendors like Honeywell International and Bosch Sensortec.

Distribution networks include medical distributors McKesson Corporation, Cardinal Health, and Henry Schein, and the firm sells through pharmacy chains including Walgreens Boots Alliance and CVS Health for consumer-facing products. Logistics partners include DHL, FedEx, and UPS for global shipments, with regional warehouses in Singapore, Switzerland, and United Arab Emirates.

Regulatory and Safety Considerations

Regulatory submissions reference guidelines from the Food and Drug Administration Center for Devices and Radiological Health and conformity assessments under the European Union Medical Device Regulation framework. Clinical data for safety and effectiveness are collected according to protocols registered with ClinicalTrials.gov and overseen by institutional review boards at Massachusetts General Hospital and Stanford Health Care. Post-market surveillance uses adverse event reporting aligned with U.S. Centers for Medicare & Medicaid Services and vigilance systems coordinated with national competent authorities.

Cybersecurity and patient data protections are designed to meet standards promoted by Health Level Seven International and privacy frameworks influenced by European Data Protection Board and Office for Civil Rights (HHS). Product recalls and corrective actions follow procedures modeled after cases adjudicated by U.S. Court of Appeals and enforcement actions from Federal Trade Commission when applicable.

Market Position and Competitors

EOne competes with established manufacturers including Philips, Medtronic, Becton Dickinson, ResMed, Smiths Medical, Boston Scientific, Abbott Laboratories, Dexcom, Insulet Corporation, AstraZeneca (in respiratory therapeutics partnerships), Boehringer Ingelheim, Fresenius Medical Care, and Stryker Corporation. The company positions itself between startups like Verily, Tandem Diabetes Care, Propeller Health, Omron Healthcare, and larger conglomerates such as Siemens Healthineers and Johnson & Johnson. Market analyses reference reports by Deloitte, McKinsey & Company, PwC, and Gartner for strategic planning and competitive benchmarking.

Category:Medical device companies